China Medical & HealthCare Group Limited

China Medical & HealthCare Group Limited

COLRF
China Medical & HealthCare Group LimitedUS flagOther OTC
0.08
USD
- -
- -
123.01MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.06
2.02
1.33
3.76
1.75
1.5
1.63
1.63
2
1.97
1.7
1.5
1.51
Basic EPS, GAAP
-1.42
1.71
0.43
-1.23
-0.1
-0.19
0.05
-0.15
-0.19
-0.17
0.02
0.03
-0.02
Free Cash Flow per Basic Share
0.85
0.02
1.07
-0.52
0.08
1.25
-0.13
-0.16
0.09
-0.09
0.17
-0.08
-0.06
Dividend per Share
- -
- -
0.1
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.02
Book Value per Share
0.11
1.82
1.69
0.2
0.08
0.01
0.01
-0.24
-0.42
-0.48
-0.36
1.8
1.78
Tangible Book Value per Share
2.69
4.14
3.73
3.18
2.75
2.44
2.44
2.41
2.35
2.1
2.03
1.74
1.72
Basic Weighted Avg Shares
549
543
536
638
732
732
732
732
732
729
924
1,086
1,083
Sales/Revenue/Turnover
34
1,096
715
2,400
1,284
1,101
1,196
1,194
1,463
1,438
1,569
1,627
1,638
Operating Margin (%)
19.68
-0.73
-9.77
-3.64
3.31
-6.8
0.36
-0.53
2.42
- -
3.63
6.18
3.23
Depreciation Expense
61
91
92
103
100
106
- -
116
105
105
93
97
93
Net Income, GAAP
-781
928
228
-783
-72
-137
35
-112
-137
-124
15
29
-27
Effective Tax Rate (%)
- -
4.51
9.86
- -
- -
- -
- -
- -
- -
- -
36.54
26.36
- -
Profit Margin (%)
-2,282.54
84.63
31.95
-32.64
-5.59
-12.46
2.92
-9.37
-9.38
-8.59
0.94
1.77
-1.64
Working Capital
49
644
470
57
297
81
-125
-133
-356
-97
216
194
114
LT Debt
610
484
270
146
474
510
233
433
366
428
483
444
434
Total Equity
1,491
2,265
2,011
2,078
2,042
1,819
1,818
1,801
1,717
1,535
1,872
1,895
1,859
Return on Invested Capital (%)
- -
-0.16
-1.34
- -
- -
- -
- -
- -
- -
- -
1.34
2.64
- -
Return on Capital (%)
- -
29.95
11.65
- -
- -
- -
- -
- -
- -
- -
5.6
2.18
- -
Return on Common Equity (%)
-173.73
177.47
24.12
-151.52
-78.2
-424.29
481.86
-1,545.97
- -
- -
- -
- -
-1.38

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.43%
1.21%
-1.9%
Free Cash Flow
18.46%
-173.86%
-20.42%
Net Income, GAAP
-118.54%
-39.28%
-193.2%
Sales/Revenue/Turnover
21.77%
6.86%
0.67%
Total Cash Common Dividend
- -
- -
108.66%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,569
2024
- -
- -
- -
- -
1,627
2025
- -
- -
- -
- -
1,638

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
-0.02

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.02

Company Description

APIChat
CEO
Meibao Guo
Full Time Employees
2,626
Sector
Healthcare
Industry
Medical - Care Facilities
Address
China Online Centre Wan Chai Hong Kong
IPO Date
Apr 17, 2014
Business
Tian An Medicare Limited, formerly China Medical & HealthCare Group Limited, is an investment holding company that primarily operates hospitals and provides integrated healthcare and eldercare services in the People's Republic of China, with additional operations in Hong Kong. The company operates through six key segments including healthcare, which encompasses hospital management and operations such as Nanjing Tongren Hospital and Kunming Tongren Hospital featuring specialized departments in otorhinolaryngology, ophthalmology, neurology, and medical imaging; eldercare, involving property development and project management for health campuses with elderly nursing homes, service apartments, independent living units, shopping malls, retail shops, and club facilities like Shanghai Tide Health Campus; property development for residential and commercial properties; property investment through leasing of residential and office spaces; financial services; and securities trading and investments in Hong Kong and overseas markets. Founded in 1989 and headquartered at 47/F, United Asia Finance Centre, 333 Lockhart Road, Wan Chai, Hong Kong, the company targets patients, elderly residents, property buyers, investors, and financial clients primarily in the PRC. In April 2024, the company changed its name from China Medical & HealthCare Group Limited to Tian An Medicare Limited to better align with its strategic focus on healthcare and eldercare operations; it maintains its stock listing under ticker 383 on the Hong Kong Stock Exchange and COLRF on OTC markets, with ongoing emphasis on sustainable development as outlined in its 2023 ESG report.